NOVEL DELIVERY SYSTEM FOR PROTEINS USING COLLAGEN AS A CARRIER MATERIAL - THE MINIPELLET

被引:68
作者
FUJIOKA, K [1 ]
TAKADA, Y [1 ]
SATO, S [1 ]
MIYATA, T [1 ]
机构
[1] KOKEN BIOSCI INST,TOKYO 152,JAPAN
关键词
INTERFERON; COLLAGEN; BIODEGRADABLE; CONTROLLED RELEASE; MINIPELLET;
D O I
10.1016/0168-3659(94)00107-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
It is critical to develop effective delivery systems for biologically active peptides and proteins since most of them are rapidly destroyed by the body. In this study, interferon (IFN) was used as a model protein drug and matrix type formulations were prepared with natural biodegradable polymers, albumin, gelatin and collagen. The release of IFN from albumin and gelatin was much faster than that of collagen in vitro. The release of IFN from the collagen matrix varied with various processing conditions and were explained based on the density of collagen matrix. IFN was constantly released with a cylindrical solid dosage form prepared by extrusion and air-drying of a 30% (w/w) collagen solution of a high concentration in vitro. Pharmacokinetic studies in mice showed that the serum IFN concentration was maintained for a long time with this solid formulation called minipellet. The advantages of the minipellet are (1) carrier material is a biodegradable natural protein; (2) it is manufactured under mild processing conditions without any organic solvent or heating process; and (3) it is easily administered in the same way as conventional injections. Therefore, it is applicable to various kinds of biologically active peptides and proteins and expected to facilitate their potential therapeutic use.
引用
收藏
页码:307 / 315
页数:9
相关论文
共 33 条
[1]   SYSTEMIC DELIVERY OF THERAPEUTIC PEPTIDES AND PROTEINS [J].
BANGA, AK ;
CHIEN, YW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 48 (1-3) :15-50
[2]  
CAMERON WJ, 1978, OBSTET GYNECOL, V51, P118
[3]  
CHVAPIL M, MODERN TRENDS VASCUL, V1, P120
[4]  
CHVAPIL M, 1973, INT REV CONNECTIVE T, V6, P21
[5]  
DIANZANI F, 1992, J INTERFERON RES, P109
[6]  
DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
[7]   ALTERED PHARMACOLOGIC PROPERTIES OF LIPOSOME-ASSOCIATED HUMAN INTERFERON-ALPHA .2. [J].
EPPSTEIN, DA .
JOURNAL OF INTERFERON RESEARCH, 1982, 2 (01) :117-125
[8]  
FUJIWARA T, 1990, CANCER RES, V50, P7003
[9]   A BIODEGRADABLE DELIVERY SYSTEM FOR PEPTIDES - PRECLINICAL EXPERIENCE WITH THE GONADOTROPIN-RELEASING-HORMONE AGONIST ZOLADEX [J].
FURR, BJA ;
HUTCHINSON, FG .
JOURNAL OF CONTROLLED RELEASE, 1992, 21 (1-3) :117-127
[10]   MACROMOLECULAR DIFFUSION THROUGH COLLAGEN MEMBRANES [J].
GILBERT, DL ;
OKANO, T ;
MIYATA, T ;
KIM, SW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 47 (1-3) :79-88